KYMR News
Kymera Therapeutics, Inc.
$136.70
+$4.97(+3.77%)
57
Overall
50
Value
66
Tech
55
Quality
Market Cap
$11.67B
Volume
620.17K
52W Range
$58.87 - $138.00
Target Price
$143.25
KYMR news: the latest Kymera Therapeutics, Inc. headlines, press releases and market updates, newest first.
Latest KYMR News
- Leerink Partners Reaffirms Their Buy Rating on Kymera Therapeutics (KYMR)TipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- Kymera Therapeutics (KYMR) Gets a Buy from BTIGTipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- KT-621 Formulation Study: What Kymera’s New Phase 1 Update Means for InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 30, 2026
- Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Kymera Therapeutics (KYMR)TipRanks Newsroom · Oct 30, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Oct 27, 2026
- Citi Remains a Buy on Kymera Therapeutics (KYMR)TipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $136.70 | +3.8% | 620.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW